Lloyd Inc Recalls Subpotent Thyro-Tab 0.050mg Bulk Tablets
Lloyd Inc is recalling 1,924,297 bulk Thyro-Tab 0.050mg tablets because they failed potency testing at the 9-month interval. The product was distributed nationwide and to Puerto Rico.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which is a reasonable probability of temporary or medically reversible health consequences. The hazard is subpotency (low potency), which is a lower risk than contamination or mislabeling of a critical allergen, and no injuries or illnesses are reported.
Plain-English summary
Lloyd Inc is voluntarily recalling 1,924,297 bulk tablets of Thyro-Tab 0.050mg. The product is packaged in bulk drums intended for repackaging and bears the firm name Lloyd Pharmaceutical, Shenandoah, IA. The specific lot number is HB06311.
The recall was initiated because the product was found to be subpotent, specifically showing low assay results at the 9-month test interval. This means the tablets may not contain the full labeled amount of the active ingredient, potentially rendering them less effective for treating thyroid conditions.
The affected product was distributed nationwide and to Puerto Rico. Because the product is in bulk form for repackaging, it is likely held by pharmaceutical distributors or repackagers rather than directly by consumers. Individuals or entities in possession of this specific lot should stop using it and contact Lloyd Inc or their supplier for instructions on return or disposal.
The recalled product
- Product
- Thyro-Tab 0.050mg., packaged in bulk drums for repackaging. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
- Manufacturer
- Lloyd Inc
- Category
- Drug — Bulk Pharmaceutical
- Hazard
- Affected units
- 1,924,297
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot HB06311
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Lloyd Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Lloyd Inc
See all →- ModerateLloyd Inc Recalls Subpotent Levothroid Levothyroxine Sodium Tablets
FDA (Drugs) · 2012-07-04
- SevereLloyd Inc Recalls Subpotent Thyro-Tab 0.75 mg Tablets
FDA (Drugs) · 2012-07-04
- ModerateLloyd Inc Recalls Subpotent Levothroid Levothyroxine Sodium Tablets
FDA (Drugs) · 2012-07-04
Same hazard · subpotent drug
See all →- ModerateAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02